97612985 - C CYCLACEL

Information

• Trademark
• 97612985

• Source

• Serial Number

  97612985

• Registration Number

  7293239

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  September 29, 2022
  2 years ago

• Registration Date

  January 30, 2024
  11 months ago

• Transaction Date

  January 30, 2024
  11 months ago

• Status Date

  January 30, 2024
  11 months ago

• Published for Opposition Date

  November 14, 2023
  a year ago

• Location Date

  January 30, 2024
  11 months ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  CALLAGHAN, BRIAN P

• Attorney Docket Number

  DYOUNG-66-T

  Attorney Name

  Jeffrey A. Smith

  Law Office Assigned Location Code

  L80

• Owners

  • Cyclacel Limited

Case File Statements

• DM0000: The mark consists of the word CYCLACEL shown in black with a highly stylized letter C comprised of five curved bands shown in light blue with seven black graduated dots.
• GS0051: Pharmaceutical products for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; pharmaceutical substances and preparations for the treatment of cancer, hematological disorders; pharmaceutical substances and preparations for use in oncology, hematology; medical preparations for the treatment of cancer and hematological disorders; medical substances in the nature of pharmaceuticals for the treatment of oncological diseases and preparations for use in oncology; medicinal preparations for the treatment of cancer and hematological disorders; medical substances in the nature of pharmaceuticals for the treatment of cancer and hematological disorders; pharmaceutical preparations for human use for the treatment of cancer and hematological disorders
• CC0000: The color(s) light blue and black is/are claimed as a feature of the mark.
• TR0010: The wording CYCLACEL has no meaning in a foreign language.
• GS0421: Pharmaceutical development; pharmaceutical products development; development of pharmaceuticals for the treatment of cancer; development of products for the treatment of cancer; development of pharmaceuticals for the treatment of leukemia; development of pharmaceuticals for the treatment of hematological cancers; development of products for the treatment of leukemia; development of products for the treatment of hematological cancers

Case File Event Statements

• 1/30/2024 - 11 months ago

  17 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC

• 1/30/2024 - 11 months ago

  16 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 11/14/2023 - a year ago

  15 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 11/14/2023 - a year ago

  14 - PUBLISHED FOR OPPOSITION Type: PUBO

• 10/25/2023 - a year ago

  13 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 10/6/2023 - a year ago

  12 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 10/6/2023 - a year ago

  11 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 10/6/2023 - a year ago

  10 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 10/6/2023 - a year ago

  9 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 10/6/2023 - a year ago

  8 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 7/21/2023 - a year ago

  7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 7/21/2023 - a year ago

  6 - NON-FINAL ACTION E-MAILED Type: GNRT

• 7/21/2023 - a year ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 7/13/2023 - a year ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 10/18/2022 - 2 years ago

  3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC

• 10/17/2022 - 2 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 10/3/2022 - 2 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP